A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.
Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much ...
Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results